215 related articles for article (PubMed ID: 23429748)
1. Neuroendocrine tumours: cracking the epigenetic code.
Karpathakis A; Dibra H; Thirlwell C
Endocr Relat Cancer; 2013 Jun; 20(3):R65-82. PubMed ID: 23429748
[TBL] [Abstract][Full Text] [Related]
2. NETs: organ-related epigenetic derangements and potential clinical applications.
Cives M; Simone V; Rizzo FM; Silvestris F
Oncotarget; 2016 Aug; 7(35):57414-57429. PubMed ID: 27418145
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic drivers of neuroendocrine tumours (NET).
Di Domenico A; Wiedmer T; Marinoni I; Perren A
Endocr Relat Cancer; 2017 Sep; 24(9):R315-R334. PubMed ID: 28710117
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.
Mapelli P; Aboagye EO; Stebbing J; Sharma R
Oncogene; 2015 Aug; 34(34):4439-47. PubMed ID: 25435371
[TBL] [Abstract][Full Text] [Related]
5. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
Pipinikas CP; Berner AM; Sposito T; Thirlwell C
Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
[TBL] [Abstract][Full Text] [Related]
7. Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids.
Dreijerink KM; Derks JL; Cataldo I; Scarpa A; Valk GD; Speel EJ
Front Horm Res; 2015; 44():115-38. PubMed ID: 26303708
[TBL] [Abstract][Full Text] [Related]
8. Genetics and epigenetics in small intestinal neuroendocrine tumours.
Stålberg P; Westin G; Thirlwell C
J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of SST
Klomp MJ; Refardt J; van Koetsveld PM; Campana C; Dalm SU; Dogan F; van Velthuysen MF; Feelders RA; de Herder WW; Hofland J; Hofland LJ
Front Endocrinol (Lausanne); 2023; 14():1184436. PubMed ID: 37223009
[TBL] [Abstract][Full Text] [Related]
10. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS
Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898
[TBL] [Abstract][Full Text] [Related]
11. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
Scarpa A
Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
[TBL] [Abstract][Full Text] [Related]
12. Gastroenteropancreatic endocrine tumors.
Meeker A; Heaphy C
Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
Larsson C
Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267
[TBL] [Abstract][Full Text] [Related]
14. Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours.
Kajiura K; Takizawa H; Morimoto Y; Masuda K; Tsuboi M; Kishibuchi R; Wusiman N; Sawada T; Kawakita N; Toba H; Yoshida M; Kawakami Y; Naruto T; Imoto I; Tangoku A; Kondo K
Lung Cancer; 2017 Sep; 111():116-123. PubMed ID: 28838380
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.
Finnerty BM; Gray KD; Moore MD; Zarnegar R; Fahey Iii TJ
World J Gastrointest Oncol; 2017 Sep; 9(9):341-353. PubMed ID: 28979716
[TBL] [Abstract][Full Text] [Related]
16. Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead.
Colao A; de Nigris F; Modica R; Napoli C
Front Endocrinol (Lausanne); 2020; 11():604341. PubMed ID: 33384663
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites.
Pareja F; Vahdatinia M; Marchio C; Lee SSK; Da Cruz Paula A; Derakhshan F; da Silva EM; Selenica P; Dopeso H; Chandarlapaty S; Wen HY; Vincent-Salomon A; Brogi E; Weigelt B; Reis-Filho JS
J Clin Pathol; 2022 Jan; 75(1):10-17. PubMed ID: 33148628
[TBL] [Abstract][Full Text] [Related]
18. Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium.
Mafficini A; Scarpa A
J Endocrinol; 2018 Mar; 236(3):R161-R167. PubMed ID: 29321190
[TBL] [Abstract][Full Text] [Related]
19. Hypo-methylation mediates chromosomal instability in pancreatic NET.
Marinoni I; Wiederkeher A; Wiedmer T; Pantasis S; Di Domenico A; Frank R; Vassella E; Schmitt A; Perren A
Endocr Relat Cancer; 2017 Mar; 24(3):137-146. PubMed ID: 28115389
[TBL] [Abstract][Full Text] [Related]
20. Dictating genomic destiny: Epigenetic regulation of pancreatic neuroendocrine tumours.
Gundara JS; Jamal K; Kurzawinski T
Mol Cell Endocrinol; 2018 Jul; 469():85-91. PubMed ID: 28385665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]